Abstract | BACKGROUND: Patients with biventricular assist device (BiVAD) placement have a poor prognosis, but preoperative risk factors for the necessity of BiVAD have not been fully elucidated. METHODS AND RESULTS: Data from 79 patients who received left ventricular assist device (LVAD) between November 2002 and December 2011 were retrospectively reviewed. Overall, 9 patients (11.4%) required BiVAD, and the survival rate of BiVAD patients was significantly lower than that of LVAD patients (P<0.001). Multivariate analysis for BiVAD requirement showed left ventricular diastolic diameter (LVDd) ≤62 mm (odds ratio [OR], 10.97; P=0.009) to be significantly associated with BiVAD requirement. Preoperative central venous pressure (CVP)/pulmonary capillary wedge pressure (PCWP) ratio ≥0.5 (OR, 13.09; P=0.028) was also significantly associated with BiVAD requirement. A new scoring system for predicting BiVAD requirement was created from the combination of CVP/PCWP ratio (≥0.5), body surface area (≤1.4 m(2)), preoperative continuous hemodiafiltration use, B-type natriuretic peptide (≥1,200 pg/ml) and LVDd (≤62 mm), and this had a significantly larger area under the curve (0.909; P=0.003) than right ventricular stroke work index on receiver operating characteristic analysis. A score >20 using the new scoring method indicated significantly high probability of BiVAD requirement (OR, 16.00; P=0.019). CONCLUSIONS: The new scoring method, which includes CVP/PCWP ratio, is a novel risk stratification tool for BiVAD therapy.
|
Authors | Taro Shiga, Koichiro Kinugawa, Teruhiko Imamura, Naoko Kato, Miyoko Endo, Toshiro Inaba, Hisataka Maki, Masaru Hatano, Atsushi Yao, Takashi Nishimura, Yasunobu Hirata, Shunei Kyo, Minoru Ono, Ryozo Nagai |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 76
Issue 12
Pg. 2785-91
( 2012)
ISSN: 1347-4820 [Electronic] Japan |
PMID | 22878403
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Natriuretic Peptide, Brain
|
Topics |
- Adult
- Biomarkers
(blood)
- Body Surface Area
- Cardiac Resynchronization Therapy
(adverse effects, mortality)
- Cardiac Resynchronization Therapy Devices
- Central Venous Pressure
- Decision Support Techniques
- Female
- Heart Failure
(blood, diagnosis, mortality, physiopathology, therapy)
- Heart-Assist Devices
- Hemodiafiltration
(adverse effects)
- Humans
- Japan
(epidemiology)
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Natriuretic Peptide, Brain
(blood)
- Odds Ratio
- Pulmonary Wedge Pressure
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Ventricular Function, Left
- Ventricular Function, Right
|